{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:52:34Z","timestamp":1793145154759,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s10096-023-04686-7","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T08:02:31Z","timestamp":1698825751000},"page":"33-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of posaconazole prophylaxis and antifungal treatment on BAL GM performance in hematology malignancy patients with febrile neutropenia: a real life experience"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6375-1472","authenticated-orcid":false,"given":"Nil\u00fcfer Aylin","family":"Acet-\u00d6zt\u00fcrk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilara","family":"\u00d6mer-Top\u00e7u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00fcbra","family":"Vurat Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zge","family":"Ayd\u0131n-G\u00fc\u00e7l\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u0307brahim Ethem","family":"P\u0131nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi","family":"Demird\u00f6\u011fen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asl\u0131","family":"G\u00f6rek-Dilekta\u015fl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Kazak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vildan","family":"\u00d6zkocaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Ursavas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahir","family":"\u00d6zkalemka\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beyza","family":"Ener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u0131dvan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halis","family":"Akal\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,1]]},"reference":[{"issue":"5","key":"4686_CR1","doi-asserted-by":"publisher","first-page":"CD012399","DOI":"10.1002\/14651858.CD012399.pub2","volume":"5","author":"K de Heer","year":"2019","unstructured":"de Heer K, Gerritsen MG, Visser CE, Leeflang MM (2019) Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev 5(5):CD012399. https:\/\/doi.org\/10.1002\/14651858.CD012399.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"4686_CR2","doi-asserted-by":"publisher","first-page":"5471","DOI":"10.1200\/JCO.2007.12.3851","volume":"25","author":"E Robenshtok","year":"2007","unstructured":"Robenshtok E, Gafter-Gvili A, Goldberg E, Weinberger M, Yeshurun M, Leibovici L et al (2007) Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol 25:5471\u20135489. https:\/\/doi.org\/10.1200\/JCO.2007.12.3851","journal-title":"J Clin Oncol"},{"key":"4686_CR3","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1056\/NEJMoa061094","volume":"356","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ et al (2007) Posaconazole vs itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356:348\u2013359. https:\/\/doi.org\/10.1056\/NEJMoa061094","journal-title":"N Engl J Med"},{"key":"4686_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"TJ Walsh","year":"2008","unstructured":"Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA et al (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327\u2013360. https:\/\/doi.org\/10.1086\/525258","journal-title":"Clin Infect Dis"},{"key":"4686_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3324\/haematol.11665","volume":"94","author":"OA Cornely","year":"2009","unstructured":"Cornely OA, Bohme A, Buchheidt D, Einsele H, Heinz WJ, Karthaus M et al (2009) Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Haematologica 94:113\u201322. https:\/\/doi.org\/10.3324\/haematol.11665","journal-title":"Haematologica"},{"key":"4686_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/bmt.2010.175","volume":"46","author":"J Maertens","year":"2011","unstructured":"Maertens J, Marchetti O, Herbrecht R, Cornely OA, Fl\u00fcckiger U, Fr\u00eare P, Third European Conference on Infections in Leukemia Group et al (2011) European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients summary of the ECIL 3\u20132009 update. Bone Marrow Trans 46:709\u201318","journal-title":"Bone Marrow Trans"},{"issue":"5","key":"4686_CR7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s10096-020-04054-9","volume":"40","author":"Y Wu","year":"2021","unstructured":"Wu Y, Yan L, Wang H, Liu H, Xing L, Fu R et al (2021) Clinical study on empirical and diagnostic-driven (pre-emptive) therapy of voriconazole in severe aplastic anaemia patients with invasive fungal disease after intensive immunosuppressive therapy. Eur J Clin Microbiol Infect Dis 40(5):949\u2013954. https:\/\/doi.org\/10.1007\/s10096-020-04054-9","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"4686_CR8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.clinthera.2015.03.021","volume":"37","author":"R Barnes","year":"2015","unstructured":"Barnes R, Earnshaw S, Herbrecht R, Morrissey O, Slavin M, Bow E et al (2015) Economic comparison of an empirical versus diagnostic-driven strategy for treating invasive fungal disease in immunocompromised patients. Clin Ther 37(6):1317-1328.e2. https:\/\/doi.org\/10.1016\/j.clinthera.2015.03.021","journal-title":"Clin Ther"},{"issue":"1","key":"4686_CR9","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1186\/s12879-018-3584-9","volume":"18","author":"RW Dib","year":"2018","unstructured":"Dib RW, Hachem RY, Chaftari AM, Ghaly F, Jiang Y, Raad I (2018) Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies. BMC Infect Dis 18(1):656. https:\/\/doi.org\/10.1186\/s12879-018-3584-9","journal-title":"BMC Infect Dis"},{"issue":"4","key":"4686_CR10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/cid\/ciac623","volume":"76","author":"J Maertens","year":"2023","unstructured":"Maertens J, Lodewyck T, Donnelly JP, Chantepie S, Robin C, Blijlevens N et al (2023) Infectious Diseases Group and the Acute Leukemia Group of the European Organization for Research and Treatment of Cancer. Empiric vs preemptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the European Organization for Research and Treatment of Cancer. Clin Infect Dis 76(4):674\u2013682. https:\/\/doi.org\/10.1093\/cid\/ciac623","journal-title":"Clin Infect Dis"},{"issue":"6","key":"4686_CR11","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE et al (2020) Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis 71(6):1367\u20131376. https:\/\/doi.org\/10.1093\/cid\/ciz1008","journal-title":"Clin Infect Dis"},{"issue":"14","key":"4686_CR12","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK et al (2018) Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. J Clin Oncol 36(14):1443\u20131453. https:\/\/doi.org\/10.1200\/JCO.2017.77.6211","journal-title":"J Clin Oncol"},{"issue":"6","key":"4686_CR13","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101(6):1644\u20131655. https:\/\/doi.org\/10.1378\/chest.101.6.1644","journal-title":"Chest"},{"key":"4686_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"TJ Walsh","year":"2008","unstructured":"Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA et al (2008) Infectious Diseases Society of America. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327\u2013360","journal-title":"Clin Infect Dis"},{"issue":"4","key":"4686_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4274\/tjh.2017.0430","volume":"35","author":"V \u00d6zkocaman","year":"2018","unstructured":"\u00d6zkocaman V, \u00d6zkalemka\u015f F, Seyhan S, Ener B, Ursava\u015f A, Ersal T et al (2018) The outcome of antifungal prophylaxis with posaconazole in patients with acute myeloid leukemia: a single-center study. Turk J Haematol 35(4):277\u2013282. https:\/\/doi.org\/10.4274\/tjh.2017.0430","journal-title":"Turk J Haematol"},{"issue":"6","key":"4686_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/myc.12755","volume":"61","author":"J Couchepin","year":"2018","unstructured":"Couchepin J, Brunel AS, Jaton K, Meylan P, Bochud PY, Lamoth F (2018) Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients. Mycoses 61(6):350\u2013354. https:\/\/doi.org\/10.1111\/myc.12755","journal-title":"Mycoses"},{"key":"4686_CR17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R et al (2016) Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 63:e1\u2013e60. https:\/\/doi.org\/10.1093\/cid\/ciw326","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4686_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3109\/1040841X.2013.804033","volume":"41","author":"SC Heng","year":"2015","unstructured":"Heng SC, Morrissey O, Chen SC, Thursky K, Manser RL, Nation RL et al (2015) Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis. Crit Rev Microbiol 41(1):124\u2013134. https:\/\/doi.org\/10.3109\/1040841X.2013.804033","journal-title":"Crit Rev Microbiol"},{"key":"4686_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12941-015-0111-3","volume":"14","author":"M Taremi","year":"2015","unstructured":"Taremi M, Kleinberg ME, Wang EW, Gilliam BL, Ryscavage PA (2015) Galactomannan antigen detection using bronchial wash and bronchoalveolar lavage in patients with hematologic malignancies. Ann Clin Microbiol Antimicrob 14:50. https:\/\/doi.org\/10.1186\/s12941-015-0111-3","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"4686_CR20","first-page":"356","volume":"44","author":"HJ Seyfarth","year":"2001","unstructured":"Seyfarth HJ, Nenoff P, Winkler J, Krahl R, Haustein UF, Schauer J (2001) Aspergillus detection in bronchoscopically acquired material. Significance Interpretation Mycoses 44:356\u2013360","journal-title":"Significance Interpretation Mycoses"},{"issue":"3","key":"4686_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/myc.12126","volume":"57","author":"H A\u011fca","year":"2014","unstructured":"A\u011fca H, Ener B, Y\u0131lmaz E, Ursava\u015f A, Kazak E, \u00d6zkocaman V et al (2014) Comparative evaluation of galactomannan optical density indices and culture results in bronchoscopic specimens obtained from neutropenic and non-neutropenic patients. Mycoses 57(3):169\u2013175. https:\/\/doi.org\/10.1111\/myc.12126","journal-title":"Mycoses"},{"issue":"12","key":"4686_CR22","doi-asserted-by":"publisher","first-page":"e874","DOI":"10.1016\/j.ijid.2011.09.011","volume":"15","author":"Z Racil","year":"2011","unstructured":"Racil Z, Kocmanova I, Toskova M, Buresova L, Weinbergerova B, Lengerova M et al (2011) Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance. Int J Infect Dis 15(12):e874\u2013e881. https:\/\/doi.org\/10.1016\/j.ijid.2011.09.011","journal-title":"Int J Infect Dis"},{"issue":"3","key":"4686_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1086\/510535","volume":"195","author":"WW Hope","year":"2007","unstructured":"Hope WW, Kruhlak MJ, Lyman CA, Petraitiene R, Petraitis V, Francesconi A et al (2007) Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. J Infect Dis 195(3):455\u2013466. https:\/\/doi.org\/10.1086\/510535","journal-title":"J Infect Dis"},{"issue":"6","key":"4686_CR24","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jinf.2010.08.014","volume":"61","author":"SY Park","year":"2010","unstructured":"Park SY, Lee SO, Choi SH, Sung H, Kim MN, Choi CM et al (2010) Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Infect 61(6):492\u2013498. https:\/\/doi.org\/10.1016\/j.jinf.2010.08.014","journal-title":"J Infect"},{"issue":"1","key":"4686_CR25","doi-asserted-by":"publisher","first-page":"e2019065","DOI":"10.4084\/MJHID.2019.065","volume":"11","author":"M Cefalo","year":"2019","unstructured":"Cefalo M, Puxeddu E, Sarmati L, Paterno G, Fontana C, Nasso D et al (2019) Diagnostic performance and safety of bronchoalveolar lavage in thrombocytopenic haematological patients for invasive fungal infections diagnosis: a monocentric, retrospective experience. Mediterr J Hematol Infect Dis 11(1):e2019065. https:\/\/doi.org\/10.4084\/MJHID.2019.065","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"9","key":"4686_CR26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/myc.12773","volume":"61","author":"H Hammarstr\u00f6m","year":"2018","unstructured":"Hammarstr\u00f6m H, Stj\u00e4rne Aspelund A, Christensson B, Heu\u00dfel CP, Isaksson J, Kondori N et al (2018) Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients. Mycoses 61(9):623\u2013632. https:\/\/doi.org\/10.1111\/myc.12773","journal-title":"Mycoses"},{"issue":"5","key":"4686_CR27","doi-asserted-by":"publisher","first-page":"e12953","DOI":"10.1111\/tid.12953","volume":"20","author":"E Wehrle-Wieland","year":"2018","unstructured":"Wehrle-Wieland E, Affolter K, Goldenberger D, Tschudin Sutter S, Halter J, Passweg J et al (2018) Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL. Transpl Infect Dis 20(5):e12953. https:\/\/doi.org\/10.1111\/tid.12953","journal-title":"Transpl Infect Dis"},{"key":"4686_CR28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jclinepi.2019.05.002","volume":"117","author":"M Hultcrantz","year":"2020","unstructured":"Hultcrantz M, Mustafa RA, Leeflang MMG et al (2020) Defining ranges for certainty ratings of diagnostic accuracy: a GRADE concept paper. J Clin Epidemiol 117:138\u2013148. https:\/\/doi.org\/10.1016\/j.jclinepi.2019.05.002","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"4686_CR29","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/myc.13269","volume":"64","author":"SY Lim","year":"2021","unstructured":"Lim SY, Lee YW, Jung J, Kim MJ, Chong YP, Lee SO et al (2021) Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis. Mycoses 64(9):1124\u20131131. https:\/\/doi.org\/10.1111\/myc.13269","journal-title":"Mycoses"},{"issue":"11","key":"4686_CR30","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1086\/647935","volume":"49","author":"J Maertens","year":"2009","unstructured":"Maertens J, Maertens V, Theunissen K, Meersseman W, Meersseman P, Meers S et al (2009) Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis 49(11):1688\u20131693. https:\/\/doi.org\/10.1086\/647935","journal-title":"Clin Infect Dis"},{"issue":"7","key":"4686_CR31","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.bbmt.2010.11.013","volume":"17","author":"MH Nguyen","year":"2011","unstructured":"Nguyen MH, Leather H, Clancy CJ, Cline C, Jantz MA, Kulkarni V et al (2011) Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Biol Blood Marrow Transplant 17(7):1043\u20131050. https:\/\/doi.org\/10.1016\/j.bbmt.2010.11.013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"4686_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.diagmicrobio.2014.03.020","volume":"79","author":"SC Heng","year":"2014","unstructured":"Heng SC, Chen SC, Morrissey CO, Thursky K, Manser RL, De Silva HD et al (2014) Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies. Diagn Microbiol Infect Dis 79(3):322\u2013327. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.03.020","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"4686_CR33","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.1128\/JCM.42.12.5517-5522.2004","volume":"42","author":"B Musher","year":"2004","unstructured":"Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA (2004) Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 42(12):5517\u20135522. https:\/\/doi.org\/10.1128\/JCM.42.12.5517-5522.2004","journal-title":"J Clin Microbiol"},{"issue":"12","key":"4686_CR34","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1093\/cid\/ciu673","volume":"59","author":"RF Duarte","year":"2014","unstructured":"Duarte RF, S\u00e1nchez-Ortega I, Cuesta I, Arnan M, Pati\u00f1o B, Fern\u00e1ndez de Sevilla A et al (2014) Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis. Clin Infect Dis 59(12):1696\u2013702. https:\/\/doi.org\/10.1093\/cid\/ciu673","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4686_CR35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/bmt.2016.279","volume":"52","author":"RF Duarte","year":"2017","unstructured":"Duarte RF, S\u00e1nchez-Ortega I, Arnan M, Pati\u00f1o B, Ayats J, Sureda A et al (2017) Serum galactomannan surveillance may be safely withdrawn from antifungal management of hematology patients on effective antimold prophylaxis: a pilot single-center study. Bone Marrow Transplant 52(2):326\u2013329. https:\/\/doi.org\/10.1038\/bmt.2016.279","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"4686_CR36","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/myc.12060","volume":"56","author":"M Hoenigl","year":"2013","unstructured":"Hoenigl M, Seeber K, Koidl C, Buzina W, W\u00f6lfler A, Duettmann W et al (2013) Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy. Mycoses 56(4):471\u2013476. https:\/\/doi.org\/10.1111\/myc.12060","journal-title":"Mycoses"},{"issue":"12","key":"4686_CR37","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1086\/429921","volume":"40","author":"KA Marr","year":"2005","unstructured":"Marr KA, Laverdiere M, Gugel A, Leisenring W (2005) Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 40(12):1762\u20131769. https:\/\/doi.org\/10.1086\/429921","journal-title":"Clin Infect Dis"},{"issue":"5","key":"4686_CR38","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jinf.2015.02.012","volume":"70","author":"S Kimura","year":"2015","unstructured":"Kimura S, Akahoshi Y, Nakano H, Harada N, Kameda K, Ugai T et al (2015) False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantation. J Infect 70(5):520\u2013540. https:\/\/doi.org\/10.1016\/j.jinf.2015.02.012","journal-title":"J Infect"},{"issue":"1","key":"4686_CR39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.medmal.2011.10.018","volume":"42","author":"MP Gerlinger","year":"2012","unstructured":"Gerlinger MP, Rousselot P, Rigaudeau S, Billon C, Touratier S, Castaigne S et al (2012) False positive galactomannan Platelia due to piperacillin-tazobactam. Med Mal Infect 42(1):10\u201314. https:\/\/doi.org\/10.1016\/j.medmal.2011.10.018","journal-title":"Med Mal Infect"},{"issue":"9","key":"4686_CR40","doi-asserted-by":"publisher","first-page":"e005116","DOI":"10.1099\/jmmcr.0.005116","volume":"4","author":"O Lheureux","year":"2017","unstructured":"Lheureux O, Montesinos I, Taton O, Antoine M, Preiser JC, Nortier J et al (2017) False-positive galactomannan assay in broncho-alveolar lavage after enteral nutrition solution inhalation: a case report. JMM Case Rep 4(9):e005116. https:\/\/doi.org\/10.1099\/jmmcr.0.005116","journal-title":"JMM Case Rep"},{"issue":"2","key":"4686_CR41","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/mmy\/myaa084","volume":"59","author":"A Haran","year":"2021","unstructured":"Haran A, Temper V, Assous M, Bergel M, Chahanian N, Elinav H, Korem M (2021) False-positive galactomannan antigen testing in pulmonary nocardiosis. Med Mycol 59(2):206\u2013209. https:\/\/doi.org\/10.1093\/mmy\/myaa084","journal-title":"Med Mycol"},{"issue":"2","key":"4686_CR42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1399-3062.2011.00675.x","volume":"14","author":"P Vergidis","year":"2012","unstructured":"Vergidis P, Walker RC, Kaul DR, Kauffman CA, Freifeld AG, Slagle DC et al (2012) False-positive Aspergillus galactomannan assay in solid organ transplant recipients with histoplasmosis. Transpl Infect Dis 14(2):213\u2013217. https:\/\/doi.org\/10.1111\/j.1399-3062.2011.00675.x","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"4686_CR43","doi-asserted-by":"publisher","first-page":"572","DOI":"10.4103\/lungindia.lungindia_30_17","volume":"34","author":"SS Kathar","year":"2017","unstructured":"Kathar SS, Mullerpattan J, Shetty A, Udwadia ZF (2017) Bronchoalveolar lavage contamination by sterile containers: a unique and unrecognized cause of a false-positive galactomannan. Lung India 34(6):572\u2013573. https:\/\/doi.org\/10.4103\/lungindia.lungindia_30_17","journal-title":"Lung India"},{"issue":"2","key":"4686_CR44","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1128\/JCM.01940-06","volume":"45","author":"CA Hage","year":"2007","unstructured":"Hage CA, Reynolds JM, Durkin M, Wheat LJ, Knox KS (2007) Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid. J Clin Microbiol 45(2):676\u2013677. https:\/\/doi.org\/10.1128\/JCM.01940-06","journal-title":"J Clin Microbiol"},{"issue":"3","key":"4686_CR45","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/myc.12867","volume":"62","author":"D Farmakiotis","year":"2019","unstructured":"Farmakiotis D, Le A, Weiss Z, Ismail N, Kubiak DW, Koo S (2019) False positive bronchoalveolar lavage galactomannan: effect of host and cut-off value. Mycoses 62(3):204\u2013213. https:\/\/doi.org\/10.1111\/myc.12867","journal-title":"Mycoses"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04686-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-023-04686-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04686-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T12:08:59Z","timestamp":1704715739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-023-04686-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["4686"],"URL":"https:\/\/doi.org\/10.1007\/s10096-023-04686-7","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,1]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical committee approval was obtained prior to study from the institutional board (2020\u201316\/19).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"As a retrospective study, we did not apply for a consent to participate in the study from the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have read, approved, and have a consent for publication of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}